Compass Therapeutics GAAP EPS of -$0.09
Source: SeekingAlpha
2026-03-05 17:07:16 ET
More on Compass Therapeutics
- Compass Therapeutics: Exciting Clinical Updates Inbound For 2026
- Compass Therapeutics, Inc. (CMPX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Compass Therapeutics
- Historical earnings data for Compass Therapeutics
- Financial information for Compass Therapeutics
Read the full article on Seeking Alpha
For further details see:
Compass Therapeutics GAAP EPS of -$0.09
Compass Therapeutics Inc.
NASDAQ: CMPX
CMPX Trading
4.67% G/L:
$5.715 Last:
608,295 Volume:
$5.49 Open:
CMPX Latest News
March 05, 2026 07:30:00 am
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
March 02, 2026 12:49:39 pm
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing
CMPX Stock Data
$1,173,889,873
124,859,196
3.73%
36
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
